Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals (part 2 of 3)

tvnportal
1.3K
28 views
  • About
  • Export
  • Add to
INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US and Non-UK Healthcare Media Only New data show that TWYNSTA®, a once daily, single pill combination of the angiotensin II receptor blocker (ARB) telmisartan and the calcium channel blocker (CCB) amlodipine, leads to rapid and sustained blood pressure (BP) reductions that can bring most patients with previously uncontrolled hypertension on RAS inhibitor monotherapy to BP goal effectively within 4 weeks.1 The results from the TEAMSTA Switch study, pr
Powered by NewsLook.com
Producer : Business Wire

0 comments